Skip to content

Ripple v. SEC legal feud: No quick resolution in sight

Ripple v. SEC legal feud: No quick resolution in sight

After Ripple’s massive win in the case against the United States Securities and Exchange Commission (SEC), in which the agency dropped the charges against the blockchain company’s top executives, the cryptocurrency community is waiting to see the results of the final settlement.

Indeed, as legal expert John E. Deaton said earlier, the SEC now “wants $770M worth of flesh” over its embarrassment. However, another popular commentator on the case, lawyer Bill Morgan has explained why settling will not be as simple as just writing a check, as he detailed in an X thread on October 26.

Remedies heating up

Specifically, Morgan believes that the remedies phase, in this case, would “heat up, not settle,” as he shared the arguments from the letters that each of the parties had earlier sent to the court regarding the SEC’s (now blocked) motion seeking an interlocutory appeal.

As it happens, according to the SEC’s letter, the agency had claimed that the remedies phase of the proceedings would be “protracted and heavily litigated” and would include additional fact and expert discovery, as the legal expert pointed out.

Part of SEC’s letter to court. Source: Bill Morgan

On the other hand, Ripple’s letter presented more details on what this would entail, such as the “further fact development on which Ripple offers and sales qualify as institutional sales.” Indeed, Morgan shared his assumption “that not all sales the SEC asserted were institutional sales were, in fact, institutional sales.”

Issue of jurisdiction

Moreover, the blockchain company also stated that this phase would involve the clarification of “whether the SEC has jurisdiction over institutional sales transactions, considering that Ripple argued that “many did not touch the USA” and that “the court has not yet ruled on this issue,” as the lawyer explained.

Finally, in Morgan’s words, the “incredibly important and obviously highly contentious” issue is whether post-complaint sales of XRP to sophisticated commercial counterparties were in violation of securities laws, considering that most of these sales were to on-demand liquidity (ODL) customers for cross-border payments.

Part of Ripple’s letter to court. Source: Bill Morgan

As he added, “the amount at stake for such sales is very large and more than the amount for institutional sales referred to in the SEC complaint,” and they “most clearly do not seem to be investment contracts because the ODL customers do not invest in XRP and don’t expect profits from investing in it.”

Finally, Morgan concludes that “it was an undisputed fact [between] the parties that ODL transactions take seconds to complete,” adding that he didn’t think the matter was “as simple as Ripple just writing a check” at this time.

Elsewhere, the XRP token that was at the center of the whole courtroom ordeal was at press time changing hands at the price of $0.54974, which represents a decline of 1.23% on the day but still an increase of 7.93% across the week, as well as a 10.13% gain on its monthly chart, as per data on October 27.

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in 70+ cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. eToro USA LLC does not offer CFDs, only real Crypto assets available. Don’t invest unless you’re prepared to lose all the money you invest.

Read Next:

Weekly Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.